Quisitive Technology Solutions, Inc. ("Quisitive" or the "Company") is pleased to announce that two leading independent proxy advisory firms, including Institutional Shareholder Services Inc. ("ISS"), ...

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed publication entitled: ...